livemint.com
59%
493
Covid-19 vaccine in India: Bharat Biotech aims at making 700 mn doses in 2021
Bharat Biotech, said on Monday that it is aiming to produce 700 million doses of its indigenously produced Covid-19 vaccine, Covaxin this year.The announcement came a day after the vaccine manufacturer received approval for "restricted" emergency use authorization use from Drugs Controller General of India."Currently, we have 20 million doses. We are aiming to achieve 700 million doses capacity in four facilities,' he informed," Krishna Ella, chairman and managing director of Bharat Biotech, said.Ella also said that the vaccine manufacturer company expects to release the efficacy data of Covaxin's Phase 3 trials, which are currently ongoing, by March.